1. Home
  2. CIEN vs LNTH Comparison

CIEN vs LNTH Comparison

Compare CIEN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ciena Corporation

CIEN

Ciena Corporation

HOLD

Current Price

$567.40

Market Cap

70.0B

Sector

Utilities

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$99.14

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIEN
LNTH
Founded
1992
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.0B
6.5B
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
CIEN
LNTH
Price
$567.40
$99.14
Analyst Decision
Strong Buy
Buy
Analyst Count
14
6
Target Price
$382.69
$87.00
AVG Volume (30 Days)
1.8M
977.3K
Earning Date
06-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
46.55
N/A
EPS
1.03
1.80
Revenue
$4,769,507,000.00
$343,374,000.00
Revenue This Year
$30.83
N/A
Revenue Next Year
$19.87
$14.19
P/E Ratio
$553.83
$55.18
Revenue Growth
18.79
3.62
52 Week Low
$70.77
$47.27
52 Week High
$605.61
$102.66

Technical Indicators

Market Signals
Indicator
CIEN
LNTH
Relative Strength Index (RSI) 55.76 67.78
Support Level $457.71 $91.65
Resistance Level $598.84 N/A
Average True Range (ATR) 34.18 3.13
MACD -3.44 0.17
Stochastic Oscillator 65.66 66.35

Price Performance

Historical Comparison
CIEN
LNTH

About CIEN Ciena Corporation

Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: